Evaluation and assessment of cancer pain and cancer pain treatment

被引:36
作者
Caraceni, A [1 ]
机构
[1] Natl Canc Inst, Dept Anesthesia & Crit Care, Rehabil & Palliat Care Unit, Neurol Unit, I-20133 Milan, Italy
关键词
cancer pain; pain assessment; pain classification; visual analogue scale; verbal rating scale; numerical rating scale; McGill pain questionnaire; Brief Pain Inventory;
D O I
10.1034/j.1399-6576.2001.450903.x
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Evaluation and assessment are the first steps of any strategy for the management of cancer pain, and are fundamental for any clinical research project in this field. Different clinical systems for evaluation and classification of cancer pain syndromes are available and their clinical usefulness should be tested. The measurement of pain intensity is necessary to document and assess the outcome of established and new treatments. Visual analogue scales, verbal and numerical rating scales and some multidimensional tools such as the Brief Pain Inventory and the McGill Pain Questionnaire are helpful in the assessment of cancer pain provided the limitations of their validity are considered. Specific questions arise when these tools are used in long-term repeated assessments of cancer patients. Assessment and measuring techniques deserve more investigations to optimize standard valid procedures and to enable us to exchange clinical information and produce comparable data in research.
引用
收藏
页码:1067 / 1075
页数:9
相关论文
共 88 条
[1]
[Anonymous], TXB PAIN
[2]
[Anonymous], P ASP S LOND ASP FDN
[3]
DIFFERENTIAL-EFFECTS OF EPIDURAL MORPHINE IN THE TREATMENT OF CANCER-RELATED PAIN [J].
ARNER, S ;
ARNER, B .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1985, 29 (01) :32-36
[4]
TREATMENT OUTCOME IN A MULTIDISCIPLINARY CANCER PAIN CLINIC [J].
BANNING, A ;
SJOGREN, P ;
HENRIKSEN, H .
PAIN, 1991, 47 (02) :129-134
[5]
Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain [J].
Benedetti, F ;
Vighetti, S ;
Amanzio, M ;
Casadio, C ;
Oliaro, A ;
Bergamasco, B ;
Maggi, G .
PAIN, 1998, 74 (2-3) :205-211
[6]
THE EDMONTON STAGING SYSTEM FOR CANCER PAIN - PRELIMINARY-REPORT [J].
BRUERA, E ;
MACMILLAN, K ;
HANSON, J ;
MACDONALD, RN .
PAIN, 1989, 37 (02) :203-209
[7]
A PROSPECTIVE MULTICENTER ASSESSMENT OF THE EDMONTON STAGING SYSTEM FOR CANCER PAIN [J].
BRUERA, E ;
SCHOELLER, T ;
WENK, R ;
MACEACHERN, T ;
MARCELINO, S ;
HANSON, J ;
SUAREZALMAZOR, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (05) :348-355
[8]
A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL OF INTRAVENOUS LIDOCAINE IN THE TREATMENT OF NEUROPATHIC CANCER PAIN [J].
BRUERA, E ;
RIPAMONTI, C ;
BRENNEIS, C ;
MACMILLAN, K ;
HANSON, J .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (03) :138-140
[9]
Caraceni A, 1996, CANCER-AM CANCER SOC, V78, P639
[10]
Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain [J].
Caraceni, A ;
Zecca, E ;
Martini, C ;
De Conno, F .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 17 (06) :441-445